IBB vs. MNTL ETF Comparison
Comparison of iShares Nasdaq Biotechnology Index Fund (IBB) to Tema Neuroscience and Mental Health ETF (MNTL)
IBB
iShares Nasdaq Biotechnology Index Fund
IBB Description
The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$133.38
Average Daily Volume
1,149,780
184
MNTL
Tema Neuroscience and Mental Health ETF
MNTL Description
Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies. A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health. The fund is non-diversified.Grade (RS Rating)
Last Trade
$24.83
Average Daily Volume
209
37
Performance
Period | IBB | MNTL |
---|---|---|
30 Days | -8.89% | -9.33% |
60 Days | -9.93% | -8.26% |
90 Days | -7.92% | -7.44% |
12 Months | 14.08% |
26 Overlapping Holdings
Symbol | Grade | Weight in IBB | Weight in MNTL | Overlap | |
---|---|---|---|---|---|
ACAD | C | 0.29% | 1.61% | 0.29% | |
ALEC | F | 0.04% | 0.67% | 0.04% | |
ALKS | B | 0.46% | 1.47% | 0.46% | |
ALNY | D | 3.32% | 4.52% | 3.32% | |
ARVN | D | 0.15% | 0.46% | 0.15% | |
AXSM | B | 0.38% | 1.96% | 0.38% | |
BIIB | F | 2.36% | 3.57% | 2.36% | |
CRNX | C | 0.48% | 3.88% | 0.48% | |
DAWN | D | 0.09% | 2.1% | 0.09% | |
DNLI | C | 0.35% | 2.26% | 0.35% | |
DYN | F | 0.21% | 1.17% | 0.21% | |
IMVT | D | 0.18% | 1.46% | 0.18% | |
IONS | F | 0.49% | 2.66% | 0.49% | |
ITCI | B | 0.85% | 2.54% | 0.85% | |
NBIX | D | 1.22% | 4.14% | 1.22% | |
NTLA | F | 0.16% | 1.56% | 0.16% | |
PRTA | F | 0.08% | 1.03% | 0.08% | |
PTCT | B | 0.32% | 1.18% | 0.32% | |
QTRX | D | 0.05% | 0.57% | 0.05% | |
REGN | F | 5.67% | 4.53% | 4.53% | |
RNA | C | 0.49% | 2.14% | 0.49% | |
SRPT | F | 0.99% | 1.88% | 0.99% | |
SRRK | C | 0.19% | 1.09% | 0.19% | |
VRTX | C | 8.08% | 8.52% | 8.08% | |
VYGR | F | 0.03% | 0.87% | 0.03% | |
XENE | D | 0.31% | 2.25% | 0.31% |
IBB Overweight 158 Positions Relative to MNTL
Symbol | Grade | Weight | |
---|---|---|---|
GILD | B | 9.77% | |
AMGN | D | 7.32% | |
IQV | F | 3.75% | |
MTD | F | 2.58% | |
ILMN | C | 2.27% | |
WAT | B | 2.22% | |
UTHR | B | 1.7% | |
NTRA | B | 1.52% | |
INCY | B | 1.49% | |
MRNA | F | 1.45% | |
BMRN | F | 1.21% | |
INSM | D | 1.14% | |
TECH | D | 1.13% | |
CRL | D | 1.07% | |
PCVX | D | 1.03% | |
EXEL | B | 0.97% | |
MEDP | D | 0.89% | |
RVMD | B | 0.8% | |
RGEN | D | 0.75% | |
HALO | D | 0.73% | |
CYTK | D | 0.62% | |
MDGL | C | 0.59% | |
BPMC | D | 0.58% | |
BRKR | F | 0.56% | |
ROIV | D | 0.5% | |
ADMA | C | 0.48% | |
KRYS | D | 0.44% | |
BHVN | C | 0.4% | |
RARE | F | 0.4% | |
CRSP | D | 0.4% | |
ACLX | C | 0.39% | |
BBIO | F | 0.34% | |
RYTM | C | 0.34% | |
AGIO | B | 0.32% | |
NUVL | D | 0.3% | |
MRUS | D | 0.3% | |
APLS | F | 0.29% | |
FOLD | F | 0.29% | |
KYMR | C | 0.28% | |
VCYT | B | 0.28% | |
VCEL | A | 0.26% | |
TWST | F | 0.25% | |
ARWR | D | 0.25% | |
IOVA | D | 0.23% | |
IDYA | F | 0.23% | |
PTGX | D | 0.23% | |
APGE | D | 0.21% | |
LGND | B | 0.21% | |
GERN | F | 0.21% | |
SWTX | C | 0.21% | |
VERA | B | 0.2% | |
EWTX | C | 0.2% | |
WVE | C | 0.19% | |
KROS | C | 0.19% | |
FTRE | D | 0.19% | |
JANX | C | 0.19% | |
BEAM | D | 0.19% | |
AKRO | C | 0.18% | |
MNKD | B | 0.18% | |
NRIX | C | 0.17% | |
GPCR | F | 0.17% | |
NVCR | D | 0.17% | |
DVAX | C | 0.17% | |
SMMT | D | 0.17% | |
MIRM | A | 0.16% | |
XNCR | B | 0.16% | |
RXRX | F | 0.16% | |
TARS | B | 0.15% | |
BCRX | D | 0.15% | |
TXG | F | 0.15% | |
MYGN | F | 0.14% | |
TVTX | B | 0.14% | |
ZYME | B | 0.14% | |
SNDX | D | 0.13% | |
NVAX | F | 0.13% | |
RCKT | F | 0.13% | |
KURA | F | 0.12% | |
AUPH | B | 0.11% | |
CDNA | D | 0.11% | |
IRON | C | 0.1% | |
ARQT | D | 0.1% | |
KNSA | F | 0.09% | |
ETNB | D | 0.09% | |
ELVN | C | 0.08% | |
VIR | C | 0.08% | |
SPRY | C | 0.08% | |
RCUS | F | 0.08% | |
ADPT | C | 0.08% | |
CTKB | C | 0.08% | |
CSTL | C | 0.08% | |
COGT | D | 0.08% | |
IRWD | D | 0.07% | |
PLRX | D | 0.07% | |
AVXL | C | 0.07% | |
OLMA | F | 0.06% | |
PACB | D | 0.06% | |
CGEM | F | 0.06% | |
REPL | C | 0.06% | |
MRVI | F | 0.06% | |
RLAY | F | 0.06% | |
NUVB | C | 0.06% | |
ORIC | D | 0.05% | |
RGNX | F | 0.05% | |
URGN | F | 0.05% | |
ARCT | F | 0.05% | |
YMAB | D | 0.05% | |
ERAS | C | 0.05% | |
HUMA | F | 0.05% | |
OPK | A | 0.05% | |
ABUS | D | 0.05% | |
ANAB | F | 0.05% | |
TSHA | D | 0.04% | |
FLGT | F | 0.04% | |
SLRN | D | 0.04% | |
RVNC | F | 0.04% | |
ALLO | D | 0.04% | |
TRML | C | 0.04% | |
VERV | D | 0.04% | |
TBPH | B | 0.04% | |
TERN | F | 0.04% | |
ITOS | F | 0.03% | |
AMLX | C | 0.03% | |
SAGE | F | 0.03% | |
VNDA | C | 0.03% | |
DNA | F | 0.03% | |
MLYS | D | 0.03% | |
QURE | C | 0.03% | |
PHAT | F | 0.03% | |
KALV | F | 0.03% | |
MXCT | F | 0.03% | |
SANA | F | 0.03% | |
FDMT | F | 0.03% | |
MGTX | B | 0.03% | |
SVRA | F | 0.03% | |
OKUR | C | 0.02% | |
ATAI | B | 0.02% | |
ACRS | C | 0.02% | |
CABA | F | 0.02% | |
NAUT | F | 0.02% | |
CRBU | D | 0.02% | |
TNGX | F | 0.02% | |
FULC | F | 0.02% | |
PRME | F | 0.02% | |
THRD | C | 0.02% | |
BMEA | F | 0.02% | |
ZNTL | D | 0.02% | |
MGNX | D | 0.02% | |
AVIR | F | 0.02% | |
EDIT | F | 0.02% | |
OVID | D | 0.01% | |
BLUE | F | 0.01% | |
CHRS | F | 0.01% | |
PGEN | F | 0.01% | |
VTYX | F | 0.01% | |
LYEL | D | 0.01% | |
MRNS | F | 0.0% | |
ALXO | F | 0.0% | |
RAPT | F | 0.0% |
IBB: Top Represented Industries & Keywords
MNTL: Top Represented Industries & Keywords